<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03428152</url>
  </required_header>
  <id_info>
    <org_study_id>U1111-1205-2226</org_study_id>
    <nct_id>NCT03428152</nct_id>
  </id_info>
  <brief_title>Superior Hypogastric Blockade for Postoperative Pain</brief_title>
  <official_title>The Efficacy of Superior Hypogastric Blockade for Postoperative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Derince Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Derince Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary indication for superior hypogastric (SHP) block is visceral pelvic pain, most
      commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate.
      Percutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy,
      magnetic resonance or computed tomography. Because of the close proximity of SHP to major
      vessels, and structures like vertebral column (for posterior) and guts (for anterior) are
      being on the way of the needle, these percutaneous blocks are associated with serious
      complications. Performing SHP during hysterectomy surgery, gives advantages to rule out these
      complications by exploring the whole intraabdominal anatomy.

      The investigators' theory is to find out if SHP blocks (during pelvic surgery) are useful for
      decreasing VAS pain scores and opioid consumption for postoperative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nerve blocks are frequently used in daily practice as an anesthetic and analgesia technique
      for surgery, postoperative pain and chronic pain. Total abdominal hysterectomy causes
      significant postoperative pain. Epidural blocks are frequently preferred for postoperative
      pain control, since most of the anesthetists are skilled with neuraxial blocks. However, an
      epidural catheter placement and epidural injections have some side effects and complications.

      Pelvis is innervated by thoracolumbar and sacral segments. Autonomic (sympathetic and
      parasympathetic) and somatic (motor and sensory) nerves provide innervation of pelvis. The
      sympathetic nervous system, which transmits nociceptive messages from the viscera to brain,
      plays an important role in the transmission of visceral pain. Generally, in order to block
      transmission of nociceptive information from the pelvic viscera to the spinal cord,
      interruption of sympathetic pathways will be necessary. The sympathetic nerve block on the
      sympathetic nervous system for the management of chronic pelvic pain has been proposed at
      three main levels: ganglion impar, hypogastric plexus and L2 lumbar sympathetic blocks. By
      following the pelvic anatomy, there could be an alternative way for acute pain relief for
      abdominal hysterectomy: superior hypogastric block.

      The superior hypogastric plexus lies retroperitoneally in front of L4 as a bunch of fibers.
      As these fibers descend, at the level of L5 they divide into the hypogastric nerves. The
      hypogastric nerves pass downward from L5-S1, following the concave curve of the sacrum and
      passing on each side of the rectum to form the inferior hypogastric plexus. These nerves
      continue their downÂ¬ward course along each side of the bladder to provide innervation to the
      pelvic viscera and vasculature.

      The primary indication for superior hypogastric block (SHNB) is visceral pelvic pain, most
      commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate.
      Percutaneous SHP blocks can be done by using posterior approach (transdiscal) and
      paravertebral) and anterior techniques. All of these interventions should be done under
      guidance of ultrasonography, fluoroscopy, magnetic resonance or computed tomography. Because
      of the close proximity of SHP to major vessels, and structures like vertebral column (for
      posterior) and guts (for anterior) are being on the way of the needle, these percutaneous
      blocks are associated with complications.

      SHP block has been performed by anesthetists or surgeons in Kocaeli Derince Training and
      Research Hospital regularly since they have discovered the advantages of this block
      technique. Performing SHP block during hysterectomy surgery, gives advantages to rule out
      these complications by exploring the whole intraabdominal anatomy. Based on the complexity of
      the pelvic innervation, SHP blocks do not offer a total painless period like central
      neuraxial blocks for sure. If SHP block is performed in patients who do not have epidural
      catheters, it can be useful to decrease postoperative pain scores and opioid or NSAID
      consumption significantly.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 9, 2018</start_date>
  <completion_date type="Actual">July 24, 2018</completion_date>
  <primary_completion_date type="Actual">July 23, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>Postoperative Pain Scores</measure>
    <time_frame>postoperative 48 hour follow-up (PACU and ward)</time_frame>
    <description>Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever) (PACU: Post-anesthesia care unit) VAS-PACU: VAS scores at PACU VAS 1: VAS scores at postoperative 1st hour (ward) VAS 6: VAS scores at postoperative 6th hour (ward) VAS 12: VAS scores at postoperative 12th hour (ward) VAS 24: VAS scores at postoperative 24th hour (ward) VAS 48: VAS scores at postoperative 48th hour (ward)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Analgesic Consumption</measure>
    <time_frame>postoperative 48 hour follow-up (PACU and ward)</time_frame>
    <description>Total number of non-steroid anti-inflammatory drug (NSAID) and opioid vials that are applied to patients in post-anesthesia care unit (PACU) and at ward will be recorded.
Target VAS score for NSAID is &gt;4; if there is no response to NSAID and pain is worsening opioid drugs will be applied (this is our routine clinical practice) NSAID: Diclofenac sodium 75mg per vial; opioid: Tramadol 100mg per vial.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rescue Analgesic Time</measure>
    <time_frame>48 hours (time to the first analgesic demand will be recorded)</time_frame>
    <description>Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Operation</measure>
    <time_frame>from the induction of anesthesia and the end of the surgery</time_frame>
    <description>the time from the the first incision to the skin to skin closure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>assessed up to 1 week</time_frame>
    <description>length of hospital stay time will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Complications Due to SHP Block</measure>
    <time_frame>From the SHP block time (intraoperative) until discharge</time_frame>
    <description>intra/postoperative complications will be noted. (post-operative nausea and vomiting (PONV) or others: ie: intra-vascular local anesthetic injection, vascular puncture, hemodynamical changes after injection,.. )</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">78</enrollment>
  <condition>Superior Hypogastric Plexus Block</condition>
  <condition>Hysterectomy</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Gynecologic Disease</condition>
  <arm_group>
    <arm_group_label>Hypo</arm_group_label>
    <description>The participants with a superior hypogastric block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NoHypo</arm_group_label>
    <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>superior hypogastric block</intervention_name>
    <description>superior hypogastric blockade during surgery</description>
    <arm_group_label>Hypo</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients who are scheduled for elective hysterectomy under general anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I - II

          -  Elective hysterectomy

        Exclusion Criteria:

          -  ASA III

          -  Different kind of surgery

          -  Known allergy to local anesthetic drugs

          -  Different analgesia protocol (ie: epidural, TAP block,..)

          -  Refusal of the patient
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>patients who are scheduled for hysterectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hande G. Aytuluk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gulfem Basol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmet Kale, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Canan Balci, Assoc Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Derince Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Derince Training and Research Hospital</name>
      <address>
        <city>Kocaeli</city>
        <state>Derince</state>
        <zip>41900</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Plancarte R, de Leon-Casasola OA, El-Helaly M, Allende S, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth. 1997 Nov-Dec;22(6):562-8.</citation>
    <PMID>9425974</PMID>
  </reference>
  <reference>
    <citation>de Leon-Casasola OA, Kent E, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain. 1993 Aug;54(2):145-51.</citation>
    <PMID>8233527</PMID>
  </reference>
  <reference>
    <citation>Sindt JE, Brogan SE. Interventional Treatments of Cancer Pain. Anesthesiol Clin. 2016 Jun;34(2):317-39. doi: 10.1016/j.anclin.2016.01.004. Review.</citation>
    <PMID>27208713</PMID>
  </reference>
  <reference>
    <citation>Choi JW, Kim WH, Lee CJ, Sim WS, Park S, Chae HB. The Optimal Approach for a Superior Hypogastric Plexus Block. Pain Pract. 2018 Mar;18(3):314-321. doi: 10.1111/papr.12603. Epub 2017 Jul 6.</citation>
    <PMID>28520297</PMID>
  </reference>
  <reference>
    <citation>Turker G, Basagan-Mogol E, Gurbet A, Ozturk C, Uckunkaya N, Sahin S. A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach. Tohoku J Exp Med. 2005 Jul;206(3):277-81.</citation>
    <PMID>15942158</PMID>
  </reference>
  <reference>
    <citation>Erdine S, Yucel A, Celik M, Talu GK. Transdiscal approach for hypogastric plexus block. Reg Anesth Pain Med. 2003 Jul-Aug;28(4):304-8.</citation>
    <PMID>12945023</PMID>
  </reference>
  <results_reference>
    <citation>Rapp H, Ledin Eriksson S, Smith P. Superior hypogastric plexus block as a new method of pain relief after abdominal hysterectomy: double-blind, randomised clinical trial of efficacy. BJOG. 2017 Jan;124(2):270-276. doi: 10.1111/1471-0528.14119. Epub 2016 Jun 12.</citation>
    <PMID>27292167</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>January 30, 2018</study_first_submitted>
  <study_first_submitted_qc>February 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2018</study_first_posted>
  <results_first_submitted>July 24, 2018</results_first_submitted>
  <results_first_submitted_qc>February 17, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 3, 2019</results_first_posted>
  <last_update_submitted>February 17, 2019</last_update_submitted>
  <last_update_submitted_qc>February 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Derince Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Hande G. Aytuluk</investigator_full_name>
    <investigator_title>M.D., Principal investigator</investigator_title>
  </responsible_party>
  <keyword>superior hypogastric plexus block</keyword>
  <keyword>hysterectomy</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genital Diseases, Female</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The investigators do not prefer to share the study plan and records.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 17, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/52/NCT03428152/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hypo</title>
          <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
        </group>
        <group group_id="P2">
          <title>NoHypo</title>
          <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30">exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age &gt;65</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hypo</title>
          <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
        </group>
        <group group_id="B2">
          <title>NoHypo</title>
          <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.36" spread="6.51"/>
                    <measurement group_id="B2" value="51.63" spread="7.49"/>
                    <measurement group_id="B3" value="52" spread="6.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Turkey</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain Scores</title>
        <description>Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever) (PACU: Post-anesthesia care unit) VAS-PACU: VAS scores at PACU VAS 1: VAS scores at postoperative 1st hour (ward) VAS 6: VAS scores at postoperative 6th hour (ward) VAS 12: VAS scores at postoperative 12th hour (ward) VAS 24: VAS scores at postoperative 24th hour (ward) VAS 48: VAS scores at postoperative 48th hour (ward)</description>
        <time_frame>postoperative 48 hour follow-up (PACU and ward)</time_frame>
        <population>37 patients with a superior hypogastric block (7 was excluded); 41 patients without a superior hypogastric block (11 was excluded).</population>
        <group_list>
          <group group_id="O1">
            <title>Hypo</title>
            <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
          </group>
          <group group_id="O2">
            <title>NoHypo</title>
            <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain Scores</title>
          <description>Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever) (PACU: Post-anesthesia care unit) VAS-PACU: VAS scores at PACU VAS 1: VAS scores at postoperative 1st hour (ward) VAS 6: VAS scores at postoperative 6th hour (ward) VAS 12: VAS scores at postoperative 12th hour (ward) VAS 24: VAS scores at postoperative 24th hour (ward) VAS 48: VAS scores at postoperative 48th hour (ward)</description>
          <population>37 patients with a superior hypogastric block (7 was excluded); 41 patients without a superior hypogastric block (11 was excluded).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>VAS PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.76" spread="1.55"/>
                    <measurement group_id="O2" value="7.38" spread="1.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="3.36"/>
                    <measurement group_id="O2" value="6.66" spread="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.32"/>
                    <measurement group_id="O2" value="4.23" spread="2.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="0.74"/>
                    <measurement group_id="O2" value="3.16" spread="2.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS 24</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.68"/>
                    <measurement group_id="O2" value="2.1" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS 48</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.4"/>
                    <measurement group_id="O2" value="1.2" spread="1.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Analgesic Consumption</title>
        <description>Total number of non-steroid anti-inflammatory drug (NSAID) and opioid vials that are applied to patients in post-anesthesia care unit (PACU) and at ward will be recorded.
Target VAS score for NSAID is &gt;4; if there is no response to NSAID and pain is worsening opioid drugs will be applied (this is our routine clinical practice) NSAID: Diclofenac sodium 75mg per vial; opioid: Tramadol 100mg per vial.</description>
        <time_frame>postoperative 48 hour follow-up (PACU and ward)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypo</title>
            <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
          </group>
          <group group_id="O2">
            <title>NoHypo</title>
            <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Analgesic Consumption</title>
          <description>Total number of non-steroid anti-inflammatory drug (NSAID) and opioid vials that are applied to patients in post-anesthesia care unit (PACU) and at ward will be recorded.
Target VAS score for NSAID is &gt;4; if there is no response to NSAID and pain is worsening opioid drugs will be applied (this is our routine clinical practice) NSAID: Diclofenac sodium 75mg per vial; opioid: Tramadol 100mg per vial.</description>
          <units>vials</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>NSAID PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.4"/>
                    <measurement group_id="O2" value="0.96" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Opioid PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.3"/>
                    <measurement group_id="O2" value="0.36" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NSAID ward</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" spread="1.23"/>
                    <measurement group_id="O2" value="5.77" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Opioid ward</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0.63" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rescue Analgesic Time</title>
        <description>Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward)</description>
        <time_frame>48 hours (time to the first analgesic demand will be recorded)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypo</title>
            <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
          </group>
          <group group_id="O2">
            <title>NoHypo</title>
            <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
          </group>
        </group_list>
        <measure>
          <title>Rescue Analgesic Time</title>
          <description>Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward)</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="627" spread="352.89"/>
                    <measurement group_id="O2" value="203.83" spread="173.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Operation</title>
        <description>the time from the the first incision to the skin to skin closure.</description>
        <time_frame>from the induction of anesthesia and the end of the surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypo</title>
            <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
          </group>
          <group group_id="O2">
            <title>NoHypo</title>
            <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Operation</title>
          <description>the time from the the first incision to the skin to skin closure.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.83" spread="34.19"/>
                    <measurement group_id="O2" value="114.16" spread="34.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>length of hospital stay time will be recorded</description>
        <time_frame>assessed up to 1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypo</title>
            <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
          </group>
          <group group_id="O2">
            <title>NoHypo</title>
            <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>length of hospital stay time will be recorded</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.66" spread="0.6"/>
                    <measurement group_id="O2" value="2.96" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Complications Due to SHP Block</title>
        <description>intra/postoperative complications will be noted. (post-operative nausea and vomiting (PONV) or others: ie: intra-vascular local anesthetic injection, vascular puncture, hemodynamical changes after injection,.. )</description>
        <time_frame>From the SHP block time (intraoperative) until discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypo</title>
            <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
          </group>
          <group group_id="O2">
            <title>NoHypo</title>
            <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Complications Due to SHP Block</title>
          <description>intra/postoperative complications will be noted. (post-operative nausea and vomiting (PONV) or others: ie: intra-vascular local anesthetic injection, vascular puncture, hemodynamical changes after injection,.. )</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PONV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>others</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From the SHP block time (intraoperative) until discharge</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Hypo</title>
          <description>The participants with a superior hypogastric block
superior hypogastric block: superior hypogastric blockade during surgery</description>
        </group>
        <group group_id="E2">
          <title>NoHypo</title>
          <description>The participants without a superior hypogastric block; the patients with an epidural catheter, who receive a different block technique (ie: TAP block), or who are unsuitable for SHP block (ie: if retro-peritoneum is opened intraoperatively by the surgeon)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr</name_or_title>
      <organization>Derince Training and Research Hospital</organization>
      <phone>+905336515650</phone>
      <email>handegrbz@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

